ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients

Affiliations

• ¹ Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA.
• ² Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
• ³ Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
• ⁴ Department of Medicine, University of California, San Diego, La Jolla, California, USA.
• ⁵ Division of AIDS, National Institutes of Health, Rockville, Maryland, USA.
• ⁶ Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA.